Sign in
4

Changes in Ownership

ProMIS Neurosciences Inc. Filed Acc 0001062993-22-019774

Options or other derivatives

  • Chief Executive Officer acquired 208,334 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farfel Gail M Chief Executive Officer 2022-09-19 Grant or award · Option (right to buy) +208,334 208,334 D: show line 1 in the form
Loading xslF345X03/form4.xml…